Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Endometrial Neoplasms × Propofol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Breast Neoplasms 2 Agnosia 2 Rectal Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 22 Doxorubicin 13 Carboplatin 12 pembrolizumab 7 Radiotherapy 5 Cisplatin 5 Taxes 4 Docetaxel 4 Chemotherapy, Adjuvant 4 Brachytherapy 4 Observation 3 Filgrastim 3 trastuzumab deruxtecan 2 olaparib 2 lenvatinib 2 durvalumab 2 Tamoxifen 2 Specimen Handling 2 Ifosfamide 2 Drug Therapy 2 sintilimab 1 selinexor 1 sacituzumab govitecan 1 pertuzumab 1 nanocis 1 liposomal doxorubicin 1 ixabepilone 1 gallium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 dostarlimab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531349 2016-05-09

ECA/R

The Cleveland Clinic

Phase 3 Withdrawn

Agnosia, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡